GIP receptor agonism blocks chemotherapy-induced nausea and vomiting.
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting.
复制标题
GIP受体激动剂可阻止化疗引起的恶心和呕吐。
DOI：
10.1016/j.molmet.2023.101743
复制
发表时间：
2023-07
影响因子：
8.1
通讯作者：
Hayes, Matthew R.
中科院分区：
文献类型：
--
作者：
Borner, Tito;Reiner, Benjamin C.;Crist, Richard C.;Furst, C. Daniel;Doebley, Sarah A.;Halas, Julia G.;Ai, Minrong;Samms, Ricardo J.;De Jonghe, Bart C.;Hayes, Matthew R.
Nausea and vomiting remain life-threatening obstacles to successful treatment of chronic diseases, despite a cadre of available antiemetic medications. Our inability to effectively control chemotherapy-induced nausea and vomiting (CINV) highlights the need to anatomically, molecularly, and functionally characterize novel neural substrates that block CINV. Behavioral pharmacology assays of nausea and emesis in 3 different mammalian species were combined with histological and unbiased transcriptomic analyses to investigate the beneficial effects of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism on CINV. Single-nuclei transcriptomics and histological approaches in rats revealed a topographical, molecularly distinct, GABA-ergic neuronal population in the dorsal vagal complex (DVC) that is modulated by chemotherapy but rescued by GIPR agonism. Activation of DVCGIPR neurons substantially decreased behaviors indicative of malaise in cisplatin-treated rats. Strikingly, GIPR agonism blocks cisplatin-induced emesis in both ferrets and shrews. Our multispecies study defines a peptidergic system that represents a novel therapeutic target for the management of CINV, and potentially other drivers of nausea/emesis. GIPR agonism attenuates cisplatin-induced emesis in ferrets and shrews. Activation of hindbrain GIPR + neurons decreases malaise in cisplatin-treated rats. Cisplatin induces profound transcriptomic alternations in hindbrain GABAergic neurons. GIPR agonism may exert its anti-emetic actions by restoring GABA-ergic activity. The GIPR system represents a novel therapeutic target for the management of CINV.
登录
查看更多内容
影响因子：
7.7
作者：
Borner T;Geisler CE;Fortin SM;Cosgrove R;Alsina-Fernandez J;Dogra M;Doebley S;Sanchez-Navarro MJ;Leon RM;Gaisinsky J;White A;Bamezai A;Ghidewon MY;Grill HJ;Crist RC;Reiner BC;Ai M;Samms RJ;De Jonghe BC;Hayes MR
通讯作者：
Hayes MR
影响因子：
8.8
作者：
Borner, Tito;Workinger, Jayme L.;Doyle, Robert P.
通讯作者：
Doyle, Robert P.
影响因子：
3.7
作者：
Horn CC;Kimball BA;Wang H;Kaus J;Dienel S;Nagy A;Gathright GR;Yates BJ;Andrews PL
通讯作者：
Andrews PL
DOI：
10.1111/dom.14089
发表时间：
2020-10
期刊：
Diabetes, obesity & metabolism
影响因子：
--
作者：
Borner T;Shaulson ED;Tinsley IC;Stein LM;Horn CC;Hayes MR;Doyle RP;De Jonghe BC
通讯作者：
De Jonghe BC
影响因子：
5
作者：
Babic, Tanja;Browning, Kirsteen N.
通讯作者：
Browning, Kirsteen N.